Viridiflorene is a tricyclic sesquiterpene hydrocarbon found in several woody, cistus, and aromatic-leaf oils, but its public evidence base is dominated by identity, occurrence, and biosynthesis work rather than isolated-compound pharmacology. Within AromaForge, it is best treated as a compositional marker that contributes to resinous green profiles. Direct constituent-level human or safety evidence remains limited, so archive copy should stay conservative and chemistry focused.
Chemical identity and composition
CAS Common Chemistry lists viridiflorene under CAS 21747-46-6 with formula C15H24, and PubChem assigns it CID 10910653. Several analytical and supplier references treat viridiflorene and ledene as equivalent or closely overlapping naming in aroma databases, which matches the way some oil assays report a combined or alternative label.
Aroma and practical use
- Use the recorded woody, resinous, green, herbal descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
CAS Common Chemistry and PubChem both support viridiflorene as a chemically defined sesquiterpene hydrocarbon with formula C15H24 and CAS 21747-46-6.
CAS Common Chemistry and PubChem both support viridiflorene as a chemically defined sesquiterpene hydrocarbon with formula C15H24 and CAS 21747-46-6.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2020 fungal-synthase study described viridiflorene/viridiflorol-producing sesquiterpene synthases, reinforcing viridiflorene's place in terpene-biosynthesis literature.
A 2020 fungal-synthase study described viridiflorene/viridiflorol-producing sesquiterpene synthases, reinforcing viridiflorene's place in terpene-biosynthesis literature.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2024 review of tricyclic aromadendrene-type sesquiterpenoids named viridiflorene synthase among currently reported aromadendrene-type sesquiterpene synthases, providing family-level biosynthetic context.
A 2024 review of tricyclic aromadendrene-type sesquiterpenoids named viridiflorene synthase among currently reported aromadendrene-type sesquiterpene synthases, providing family-level biosynthetic context.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
No constituent-specific IFRA restriction, human dermal study, or dedicated toxicology paper for isolated viridiflorene was verified in the reviewed public sources.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Because accessible evidence is mainly identity and biosynthesis oriented, archive copy should not infer therapeutic benefits from the presence of viridiflorene alone.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
sesquiterpene synthase product
Recent fungal and plant terpene-synthase papers identify viridiflorene as a product of specific sesquiterpene synthases, which is useful for biosynthetic classification but not a human biological mechanism.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
no human validated mechanism
No constituent-specific human pharmacology or validated molecular mechanism for isolated viridiflorene was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human clinical studies specific to isolated viridiflorene were verified.
- Direct isolated-compound pharmacology evidence was not clearly established in accessible primary sources.
- Constituent-specific safety, sensitization, and use-limit data remain sparse.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.